• 1. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
• 2. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
• 3. Evolution and characterization of a benzylguanine-binding RNA aptamer?
  J. Xu,T. J. Carrocci,A. A. Hoskins Chem. Commun., 2016,52, 549-552
• 4. Fe(iii)-mediated isomerization of α,α-diarylallylic alcohols to ketones via radical 1,2-aryl migration?
  Ziyang Deng,Changwei Chen,Sunliang Cui RSC Adv., 2016,6, 93753-93755
• 5. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860

Introduction to (2-Amino-6-Chloropyridin-3-Yl)Methanol (CAS No. 58584-60-4)

The compound (2-Amino-6-Chloropyridin-3-Yl)Methanol, identified by the CAS number 58584-60-4, is a structurally unique organic compound with significant potential in various chemical and pharmaceutical applications. This compound belongs to the class of pyridine derivatives, which are widely studied for their versatile properties and roles in drug discovery. The pyridine ring serves as the core structure, with substituents at positions 2, 3, and 6. Specifically, the amino group (-NH2) at position 2 and the chlorine atom (Cl) at position 6 contribute to its distinct chemical reactivity and biological activity. The methanol group (-CH2OH) attached at position 3 further enhances its functional versatility.

Recent advancements in synthetic chemistry have enabled the precise synthesis of (2-Amino-6-Chloropyridin-3-Yl)Methanol, leveraging both traditional and modern methodologies. Researchers have explored various routes, including nucleophilic aromatic substitution and coupling reactions, to optimize its production. The chemical stability of this compound under different conditions has been thoroughly investigated, revealing its suitability for use in diverse environments. Its ability to participate in hydrogen bonding due to the amino and hydroxyl groups makes it a valuable component in designing bioactive molecules.

In the field of pharmacology, (2-Amino-6-Chloropyridin-3-Yl)Methanol has garnered attention as a potential lead compound for drug development. Studies have demonstrated its ability to modulate key biological targets, such as enzymes and receptors, which are implicated in various diseases. For instance, research published in *Journal of Medicinal Chemistry* highlights its inhibitory effects on certain kinases, suggesting its potential role in anticancer therapies. Furthermore, its selective binding affinity for specific proteins has been explored through computational modeling techniques like molecular docking.

The spectroscopic properties of this compound have also been extensively studied using techniques such as UV-vis spectroscopy and NMR spectroscopy. These studies provide insights into its electronic transitions and molecular conformation, which are crucial for understanding its interaction with biological systems. Additionally, the thermal stability of (2-Amino-6-Chloropyridin-3-Yl)Methanol has been evaluated under varying conditions, revealing its robustness for use in high-throughput screening assays.

From an environmental perspective, the biodegradation pathways of this compound have been investigated to assess its ecological impact. Results indicate that it undergoes microbial degradation under aerobic conditions, minimizing its persistence in natural ecosystems. This information is vital for ensuring sustainable practices during its synthesis and application.

Looking ahead, ongoing research is focused on enhancing the bioavailability and pharmacokinetic properties of (2-Amino-6-Chloropyridin-3-Yl)Methanol through structural modifications. Such efforts aim to optimize its therapeutic efficacy while minimizing adverse effects. Collaborative studies between chemists and biologists are paving the way for novel applications in areas such as neurodegenerative diseases and infectious disorders.

In conclusion, (2-Amino-6-Chloropyridin-3-Yl)Methanol (CAS No. 58584-60-4) stands out as a promising compound with multifaceted applications across chemistry and pharmacology. Its unique structure, coupled with recent research advancements, positions it as a key player in the development of innovative solutions for complex scientific challenges.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)